Researcher.Life Logo

Gene Therapy : Impact Factor & More

eISSN: 1476-5462pISSN: 0969-7128

Key Metrics

CiteScore
7.6
H-Index
169
Impact Factor
5 - 10
SJR
Q1Genetics
SNIP
0.82
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Gene Therapy

Gene Therapy Journal Specifications

Overview
Publisher SPRINGERNATURE
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Gene Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Gene Therapy

Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreatic cancer.
  • 9 Jan 2026
  • Gene therapy
The co-delivery of Programmed Death 1 ligands enhances and prolongs rAAV-mediated gene expression in pre-immunized mice.
  • 9 Jan 2026
  • Gene therapy
Metadata assessment of non-human primate studies of AAV9 uncovers potential tissue specific variation in expression efficiency.
  • 7 Jan 2026
  • Gene therapy
Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA's conclusions from the evaluation of 38 suspected cases.
  • 22 Dec 2025
  • Gene therapy
Lipid nanoparticle mediated base editing of the Q344X rhodopsin mutation associated with retinitis pigmentosa.
  • 10 Dec 2025
  • Gene therapy
Intranasal versus intravenous AAV delivery: A comparative analysis of brain-targeting efficiency and peripheral exposure in mice.
  • 8 Dec 2025
  • Gene therapy
Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreatic cancer.
  • 9 Jan 2026
  • Gene therapy
The co-delivery of Programmed Death 1 ligands enhances and prolongs rAAV-mediated gene expression in pre-immunized mice.
  • 9 Jan 2026
  • Gene therapy
Metadata assessment of non-human primate studies of AAV9 uncovers potential tissue specific variation in expression efficiency.
  • 7 Jan 2026
  • Gene therapy
Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA's conclusions from the evaluation of 38 suspected cases.
  • 22 Dec 2025
  • Gene therapy
Lipid nanoparticle mediated base editing of the Q344X rhodopsin mutation associated with retinitis pigmentosa.
  • 10 Dec 2025
  • Gene therapy
Intranasal versus intravenous AAV delivery: A comparative analysis of brain-targeting efficiency and peripheral exposure in mice.
  • 8 Dec 2025
  • Gene therapy

FAQs on Gene Therapy